Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. V Lerner, C Miodownik, A Kaptsan, Y Bersudsky, I Libov, BA Sela, ... Journal of Clinical Psychiatry 68 (11), 1648-1654, 2007 | 121 | 2007 |
Vitamin B6 in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study V Lerner, C Miodownik, A Kaptsan, H Cohen, M Matar, U Loewenthal, ... American Journal of Psychiatry 158 (9), 1511-1514, 2001 | 113 | 2001 |
Vitamin B~ 6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study V Lerner, C Miodownik, A Kaptsan, H Cohen, U Loewenthal, M Kotler Journal of Clinical Psychiatry 63 (1), 54-58, 2002 | 53 | 2002 |
Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study V Lerner, A Kaptsan, C Miodownik, M Kotler Clinical neuropharmacology 22 (4), 241-243, 1999 | 52 | 1999 |
Transcranial magnetic stimulation in an amphetamine hyperactivity model of mania A Shaldivin, A Kaptsan, RH Belmaker, H Einat, N Grisaru Bipolar disorders 3 (1), 30-34, 2001 | 32 | 2001 |
High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia V Lerner, C Miodownik, A Kaptsan, T Vishne, BA Sela, J Levine Journal of Clinical Psychiatry 66 (12), 1558-1563, 2005 | 19 | 2005 |
Oneiroid syndrome: a concept of use for western psychiatry A Kapstan, C Miodownick, V Lerner Israel Journal of Psychiatry 37 (4), 278, 2000 | 17 | 2000 |
The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel V Lerner, I Libov, A Kaptsan, C Miodownik, T Dwolatzky, J Levine Israel Journal of Psychiatry and Related Sciences 44 (1), 20, 2007 | 14 | 2007 |
The misidentification of Clerambault's and Kandinsky-Clerambault's syndromes V Lerner, A Kaptsan, E Witztum The Canadian Journal of Psychiatry 46 (5), 441-443, 2001 | 14 | 2001 |
Why switch?-motivations for self-substitution of illegal drugs B Shapira, R Berkovitz, P Rosca, S Lev-Ran, A Kaptsan, Y Neumark Substance Use & Misuse 56 (5), 627-638, 2021 | 12 | 2021 |
Factors associated with unplanned early discharges from a dual diagnosis inpatient detoxification unit in Israel MM Sofer, A Kaptsan, J Anson Journal of Dual Diagnosis 14 (3), 137-147, 2018 | 10 | 2018 |
Ziprasidone-associated depressive state in schizophrenic patients A Kaptsan, T Dwolatzky, V Lerner Clinical neuropharmacology 30 (6), 357-361, 2007 | 10 | 2007 |
Kandinsky-Clerambault's Syndrome: concept of use for Western psychiatry V Lerner, A Kaptsan, E Witztum Israel Journal of Psychiatry 40 (1), 40, 2003 | 9 | 2003 |
Delirium due to buprenorphine therapy A Kaptsan, D Telias American Journal of Case Reports 4 (3), 182-185, 2003 | 8 | 2003 |
Ethnic origin of alcoholics admitted to an Israeli treatment center A Kaptsan, D Telias, Y Bersudsky, RH Belmaker The American journal of drug and alcohol abuse 32 (4), 549-553, 2006 | 6 | 2006 |
Double-blind evaluation of vitamin B6 vs placebo in treatment of tardive dyskinesia V Lerner, C Miodownik, A Kaptsan, H Cohen, V Loewental, M Kotler European Neuropsychopharmacology, 369, 1999 | 1 | 1999 |
The effect of high doses of vitamin B-6 on tardive movement disorders: A double-blind crossover study V Lerner, C Miodownik, A Kaptsan, Y Bersudsky, I Libov, BA Sela, ... INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 9, S205-S205, 2006 | | 2006 |
Prevalence of tardive movement subsyndromes in southern region of Israel V Lerner, I Libov, A Kaptsan, C Miodownik, T Dwolatzky, J Levine EUROPEAN NEUROPSYCHOPHARMACOLOGY 15, S564-S565, 2005 | | 2005 |
Homocysteine serum level in patients with tardive dyskinesia V Lerner, C Miodownik, A Kaptsan, B Sela, J Levine INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 7, S448-S448, 2004 | | 2004 |
Add-on treatment with vitamin B 6 in chronic schizophrenic and schizoaffective patients: A double-blind placebo-controlled study V Lerner, C Miodownik, A Kaptsan, H Cohen, M Kotler European Neuropsychopharmacology, S363-S364, 2001 | | 2001 |